Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Arecor Therapeutics PLC banner
A

Arecor Therapeutics PLC
LSE:AREC

Watchlist Manager
Arecor Therapeutics PLC
LSE:AREC
Watchlist
Price: 88.5 GBX
Market Cap: £33.4m
Write Note Create Alert Ask AI

Wall St Price Targets

AREC Price Forecast
Based on 3 analysts

+218% Upside
from 88.5 GBX today

Arecor Therapeutics PLC (AREC)’s 12-month stock price forecast through September 2027 has a consensus target of 281.01 GBX, implying 218% upside. The forecast is based on price targets from 3 Wall Street analysts.

AREC Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for AREC yet.

Arecor Therapeutics PLC Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts

Continue AREC Research

Summary
AREC intrinsic value, competitors valuation, and company profile.
DCF Valuation
AREC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AREC stock valuation using valuation multiples.
Wall St Estimates
AREC price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AREC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Arecor Therapeutics PLC listings:
F • EUR
6UI
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is AREC's stock price target?
Price Target
281.01 GBX

According to Wall Street analysts, the average 1-year price target for AREC is 281.01 GBX with a low forecast of 253.51 GBX and a high forecast of 315 GBX.

What is the Revenue forecast for Arecor Therapeutics PLC?
Projected CAGR
-14%

Over the last 7 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is -14%.

Back to Top
ALPHA SPREAD
Follow us
Join 359,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.